Newswise NEW YORK, May 5, 2026 -- Calibrate, the first integrated clinical and coaching solution for obesity care, today released its 2026 Results Report which draws on one of the largest real-world datasets in behavior-assisted obesity management: more than 50,000 members drawn from nearly six years of clinical data
Our intestines naturally secrete GLP-1 when we eat, which sends signals to our pancreas to produce more insulin
MinJSJoSJLeeSKimDYKimDHLeeCBet alA comprehensive review on the pharmacokinetics and DrugDrug Interactions of approved GLP-1 receptor agonists and a dual GLP-1/GIP receptor agonist
Our therapy is particularly effective for individuals struggling with obesity and other weight-related health concerns
We avoid compounded alternatives, choosing treatments substantiated by large trials and manufactured under strict quality controls
[DOI] [PubMed] [Google Scholar] 8.Faris JE, Smith MR